Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Understanding the differences between budgeting methods can help you choose the best approach. See how zero based budgeting stacks up.
22,683 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Dream Finders' unsolicited cash offer values Beazer at about $704 million, sparking a public contest as U.S. homebuil...
Trump heads to Beijing for a high-stakes meeting with Xi Jinping, as AI chip controls and farm trade take center stag...
As AI accelerates, a handful of chipmakers stand to benefit the most. This guide highlights four brilliant chip stock...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Coinbase widens its influence in on-chain finance by becoming the official USDC deployer on Hyperliquid, a move desig...
A new DRAM-focused ETF has surged on AI memory hype but remains heavily concentrated in three producers, raising ques...
Bitcoin could be poised for further weakness if historical midterm-year patterns repeat, with analysts flagging a pot...
Investors are weighing memory constraints and AI demand against Nvidia’s growth potential beyond GPUs as the company ...
Thinking beyond quick wins, this guide shows how to build a reliable, growing income stream over two decades. Meet th...
Nvidia is poised to report fiscal Q1 2027 results as traders assess whether it can sustain a 75% gross margin amid re...
Cardano’s May 29 hard fork vote is unfolding as a practical test of governance and DeFi activity. Key infrastructure ...